在服用SSRI药物的同时服用患者中,用于治疗耐药性抑郁症的psilocybin
Guy M Goodwin1, Megan Croal2, David Feifel3
1COMPASS Pathfinder Ltd, London, United Kingdom. guy.goodwin@compasspathways.com.
概括
这项研究探讨了治疗耐药性抑郁症 (TRD) 的SSRI与psilocybin (COMP360) 的结合. 结果显示,抑郁症显著减少和耐受性,这表明了潜在的新治疗范式.
科学领域:
- 精神病学是一个精神病学.
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐治疗抑郁症 (TRD) 是一个重大的临床挑战.
- 目前的治疗方法往往需要抗抑郁药的戒断,这可能是有问题的.
- 西正在研究其潜在的抗抑郁作用.
研究的目的:
- 为了探索合成西 (COMP360) 的安全性,耐受性和疗效,作为选择性血清素再吸收抑制剂 (SSRI) 的辅助剂,在TRD的成年人中.
- 评估psilocybin对抑郁症症状严重性的影响.
- 评估治疗出现的不良事件 (TEAE) 和临床结果.
主要方法:
- 一个国际,固定的剂量,开放的标签,第二阶段的探索性研究.
- 19名TRD患者接受了单次25毫克的西剂,并得到了心理支持.
- 随访时间为3周,通过蒙哥马利-阿斯伯格抑郁评分表 (MADRS) 和临床全球印象严重性 (CGI-S) 评分来评估疗效.
主要成果:
- 在第3周,MADRS总分比基线平均减少了-14.9分.
- 在CGI-S得分的显著改善,与基线平均变化为-1.3.
- 42.1%的参与者实现了反应和缓解标准.
- 大多数治疗出现的不良事件 (TEAE) 是轻微的和短暂的,没有报告严重事件或增加自杀念头.
结论:
- 作为SSRI的辅助剂,松素 (COMP360) 在患有TRD的成年人中显示出有前途的疗效和耐受性.
- 这些发现支持在更大规模的受控试验中进一步调查,特别是对于无法停止抗抑郁药物治疗的患者.
- 这种方法可能为TRD提供一种新的治疗策略,可能避免有问题的抗抑郁药物戒断.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
275
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
275
Psychosis: Goals of Pharmacotherapy
170
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
170
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
444
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
444
Antidepressant Drugs: Overview
589
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
589
Electroconvulsive Therapy
75
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
75
Drug Therapy
73
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
73


